{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7696,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/10",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "195a72e3-042b-4b78-8bf8-d7823b8dad46",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Proven manufacturing portfolio and customer testimonials",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "other",
      "function": "establish_context",
      "notes": "The slide uses a logo-grid layout categorized by industry.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/11",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "195a72e3-042b-4b78-8bf8-d7823b8dad46",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Proven manufacturing portfolio and customer testimonials",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": "The slide uses a central product image with callouts pointing to specific features.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/12",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-12",
      "loopMatches": [
        {
          "to": 14,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "86330520-942b-4bc1-a4e5-530daaeb0485",
          "evidence": "Testimonial and growth positioning",
          "position": 2,
          "objective": "Highlight customer success and growth strategy",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "195a72e3-042b-4b78-8bf8-d7823b8dad46",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Proven manufacturing portfolio and customer testimonials",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a before/after style logic to present the ROI and cost savings.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/13",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-13",
      "loopMatches": [
        {
          "to": 14,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "86330520-942b-4bc1-a4e5-530daaeb0485",
          "evidence": "Testimonial and growth positioning",
          "position": 2,
          "objective": "Highlight customer success and growth strategy",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "195a72e3-042b-4b78-8bf8-d7823b8dad46",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Rising Success",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Proven manufacturing portfolio and customer testimonials",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a linear process flow diagram to represent growth drivers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/14",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-14",
      "loopMatches": [
        {
          "to": 14,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "86330520-942b-4bc1-a4e5-530daaeb0485",
          "evidence": "Testimonial and growth positioning",
          "position": 2,
          "objective": "Highlight customer success and growth strategy",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 14,
          "beatId": "e7c711f0-f352-4cd6-a1f3-59c663e5b01d",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "Positioning for rapid growth and management team introduction",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "team_bio",
      "function": "introduce_nominees",
      "notes": "The slide uses a grid layout to display 11 executive profiles.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/15",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 14,
          "beatId": "e7c711f0-f352-4cd6-a1f3-59c663e5b01d",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "Positioning for rapid growth and management team introduction",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a grouped bar chart format to compare year-over-year performance for each quarter.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/16",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 14,
          "beatId": "e7c711f0-f352-4cd6-a1f3-59c663e5b01d",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "Positioning for rapid growth and management team introduction",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a dark theme with yellow and white bars to distinguish between 2022 and 2023 data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/17",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 17,
          "beatId": "fd9bb950-0e1f-435a-9df7-3ef052f414ee",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "Financial review and guidance",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a dark background with yellow text for key metrics. It includes specific disclaimers regarding non-GAAP reporting and revenue guidance basis.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/18",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 17,
          "beatId": "fd9bb950-0e1f-435a-9df7-3ef052f414ee",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "Financial review and guidance",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a footnote explaining the composition of non-recurring costs for both years.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/19",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 17,
          "beatId": "fd9bb950-0e1f-435a-9df7-3ef052f414ee",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "Financial review and guidance",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes footnote detailing non-recurring costs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/20",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 17,
          "beatId": "fd9bb950-0e1f-435a-9df7-3ef052f414ee",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "Financial review and guidance",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0eca-7165-8d32-b05db7809645",
      "docSlug": "8970c52294738d5e936b16b5f3c0ac39",
      "documentTitle": "Markforged | Results Presentation Deck | 21 slides",
      "authorId": "markforged",
      "authorName": "Markforged",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The slide is purely visual, serving as a title or transition page.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0eca-7165-8d32-b05db7809645/21",
      "deckHref": "/decks/019de077-0eca-7165-8d32-b05db7809645",
      "deckAnchorHref": "/decks/019de077-0eca-7165-8d32-b05db7809645#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 21,
          "from": 17,
          "beatId": "fd9bb950-0e1f-435a-9df7-3ef052f414ee",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "Financial review and guidance",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/d9SmsMEjsblGHPAbeelRh-4CPm_Nb3qMYTUxlSYFxlI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMWE2MjMzMmRiZGZmZjZiNTRmZWIyNTQ5OGU0OWU3ZS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/1",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/GbyV-ZCqQKNruTpjRC5Jms17_IO9Dc7q7HduFqC-KRk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMWE2MjMzMmRiZGZmZjZiNTRmZWIyNTQ5OGU0OWU3ZS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/HJQAXE_5LO_DOdovh5oXBkAbsR2D66Wbr62gSyqqQd0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMWE2MjMzMmRiZGZmZjZiNTRmZWIyNTQ5OGU0OWU3ZS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/Q4W86Af3wF0kF-GDRoB9KFSt372mXeAb4MuIVZbbkMw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMWE2MjMzMmRiZGZmZjZiNTRmZWIyNTQ5OGU0OWU3ZS9wMDAxLnBuZw"
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/2",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "thesis_headline",
      "function": "present_solution",
      "notes": "The slide uses a process-flow structure to connect the technology (LNCs) to current clinical validation (MAT2203) and future pipeline expansion.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/3",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-3",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "cd8f1275-a9e5-42e0-ae56-ede12f8a89f5",
          "evidence": "The LNC platform is introduced as a clinically validated intracellular delivery platform",
          "position": 1,
          "objective": "Why does the LNC delivery platform matter?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 3,
          "beatId": "35839f94-0ed3-4c5e-9458-9eb714db57c0",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Situation & Context",
          "beatSlug": "consultants-gambit-situation-context",
          "evidence": "The LNC delivery platform and its applications are introduced",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes scientific illustration of molecular structure and bulleted list of key benefits.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/4",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-4",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "cd8f1275-a9e5-42e0-ae56-ede12f8a89f5",
          "evidence": "The LNC platform is introduced as a clinically validated intracellular delivery platform",
          "position": 1,
          "objective": "Why does the LNC delivery platform matter?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 3,
          "beatId": "35839f94-0ed3-4c5e-9458-9eb714db57c0",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Situation & Context",
          "beatSlug": "consultants-gambit-situation-context",
          "evidence": "The LNC delivery platform and its applications are introduced",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a two-part framework to explain the biological mechanism: Targeting (left) and Delivery (right).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/5",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-5",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "cd8f1275-a9e5-42e0-ae56-ede12f8a89f5",
          "evidence": "The LNC platform is introduced as a clinically validated intracellular delivery platform",
          "position": 1,
          "objective": "Why does the LNC delivery platform matter?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 3,
          "beatId": "35839f94-0ed3-4c5e-9458-9eb714db57c0",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Situation & Context",
          "beatSlug": "consultants-gambit-situation-context",
          "evidence": "The LNC delivery platform and its applications are introduced",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/6",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-6",
      "loopMatches": [
        {
          "to": 6,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "cd8f1275-a9e5-42e0-ae56-ede12f8a89f5",
          "evidence": "The LNC platform is introduced as a clinically validated intracellular delivery platform",
          "position": 1,
          "objective": "Why does the LNC delivery platform matter?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 3,
          "beatId": "35839f94-0ed3-4c5e-9458-9eb714db57c0",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Situation & Context",
          "beatSlug": "consultants-gambit-situation-context",
          "evidence": "The LNC delivery platform and its applications are introduced",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "why_now",
      "function": "frame_problem",
      "notes": "Uses authority-citation to establish the urgency of the problem.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/7",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-7",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 7,
          "from": 7,
          "beatId": "e8cc6cc0-fc31-4326-9fc7-e1ac3fcc814d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The growing threat of IFIs is highlighted as a problem",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a before-after-bridge style logic to frame the solution.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/8",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-8",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 8,
          "beatId": "4eb8e5ad-84ec-492e-aa66-8090e8dc6c85",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "MAT2203 is presented as a solution to the problem of limited treatment options for IFIs",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "traction",
      "function": "show_traction",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/9",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-9",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "56364061-eb35-4da2-9296-61758579e6b7",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Clinical validation and results of EnACT are presented",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "This is a validation slide showing scientific credibility through peer-reviewed publication.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/10",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-10",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "56364061-eb35-4da2-9296-61758579e6b7",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Clinical validation and results of EnACT are presented",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a human silhouette as a central anchor to map specific medical conditions to anatomical locations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/11",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-11",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "56364061-eb35-4da2-9296-61758579e6b7",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Clinical validation and results of EnACT are presented",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Highlights clinical success in patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/12",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-12",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "56364061-eb35-4da2-9296-61758579e6b7",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Clinical validation and results of EnACT are presented",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "Includes a timeline of clinical events and longitudinal charts for Creatinine and Potassium levels.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/13",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-13",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 9,
          "beatId": "56364061-eb35-4da2-9296-61758579e6b7",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Evidence & Proof",
          "beatSlug": "consultants-gambit-evidence-proof",
          "evidence": "Clinical validation and results of EnACT are presented",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide highlights the limitations of current first-line azole treatments and identifies a specific patient sub-segment with high unmet need.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/14",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-14",
      "loopMatches": [
        {
          "to": 14,
          "from": 7,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "152bbf1c-1860-4dec-b978-15c2f9ed0c98",
          "evidence": "The high unmet medical need in IA and the growing threat of IFIs are highlighted",
          "position": 0,
          "objective": "What is the cost of not addressing the growing threat of IFIs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 14,
          "beatId": "d61187bc-5128-49c9-99e9-db5df1690edf",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The high unmet medical need in invasive aspergillosis (IA) is emphasized",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Mentions specific regulatory pathways (LPAD, QIDP, ODD, Fast-Track) and the ORALTO trial.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/15",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-15",
      "loopMatches": [
        {
          "to": 29,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "c020a8cd-19c2-4f66-b8fd-1a6de00826c3",
          "evidence": "The regulatory and development strategy for MAT2203 and the LNC platform are presented",
          "position": 2,
          "objective": "What are the near-term milestones and potential for growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a non-inferiority trial design comparing oral MAT2203 to IV LAMB/SoC.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/16",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-16",
      "loopMatches": [
        {
          "to": 29,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "c020a8cd-19c2-4f66-b8fd-1a6de00826c3",
          "evidence": "The regulatory and development strategy for MAT2203 and the LNC platform are presented",
          "position": 2,
          "objective": "What are the near-term milestones and potential for growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a combination of an additive equation for the value prop and a chevron-based timeline for lifecycle management.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/17",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-17",
      "loopMatches": [
        {
          "to": 29,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "c020a8cd-19c2-4f66-b8fd-1a6de00826c3",
          "evidence": "The regulatory and development strategy for MAT2203 and the LNC platform are presented",
          "position": 2,
          "objective": "What are the near-term milestones and potential for growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "docSlug": "f1a62332dbdfff6b54feb25498e49e7e",
      "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 29 slides",
      "authorId": "matinas-biopharma",
      "authorName": "Matinas BioPharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "transition",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0f5f-77ef-a5cf-60b15fd5a5a5/18",
      "deckHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5",
      "deckAnchorHref": "/decks/019de077-0f5f-77ef-a5cf-60b15fd5a5a5#slide-18",
      "loopMatches": [
        {
          "to": 29,
          "from": 15,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "c020a8cd-19c2-4f66-b8fd-1a6de00826c3",
          "evidence": "The regulatory and development strategy for MAT2203 and the LNC platform are presented",
          "position": 2,
          "objective": "What are the near-term milestones and potential for growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}